192 related articles for article (PubMed ID: 24415516)
1. Stage-specific associations between beta blocker use and prognosis after colorectal cancer.
Jansen L; Hoffmeister M; Arndt V; Chang-Claude J; Brenner H
Cancer; 2014 Apr; 120(8):1178-86. PubMed ID: 24415516
[TBL] [Abstract][Full Text] [Related]
2. Beta blocker use and colorectal cancer risk: population-based case-control study.
Jansen L; Below J; Chang-Claude J; Brenner H; Hoffmeister M
Cancer; 2012 Aug; 118(16):3911-9. PubMed ID: 22585669
[TBL] [Abstract][Full Text] [Related]
3. Pre- and post-diagnostic beta-blocker use and prognosis after colorectal cancer: Results from a population-based study.
Jansen L; Weberpals J; Kuiper JG; Vissers PAJ; Wolkewitz M; Hoffmeister M; Brenner H
Int J Cancer; 2017 Jul; 141(1):62-71. PubMed ID: 28370155
[TBL] [Abstract][Full Text] [Related]
4. Smoking and survival of colorectal cancer patients: population-based study from Germany.
Walter V; Jansen L; Hoffmeister M; Ulrich A; Chang-Claude J; Brenner H
Int J Cancer; 2015 Sep; 137(6):1433-45. PubMed ID: 25758762
[TBL] [Abstract][Full Text] [Related]
5. Statin use and survival after colorectal cancer: the importance of comprehensive confounder adjustment.
Hoffmeister M; Jansen L; Rudolph A; Toth C; Kloor M; Roth W; Bläker H; Chang-Claude J; Brenner H
J Natl Cancer Inst; 2015 Jun; 107(6):djv045. PubMed ID: 25770147
[TBL] [Abstract][Full Text] [Related]
6. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
Grytli HH; Fagerland MW; Fosså SD; Taskén KA
Eur Urol; 2014 Mar; 65(3):635-41. PubMed ID: 23351721
[TBL] [Abstract][Full Text] [Related]
7. Survival impact of surgical resection of primary tumor in patients with stage IV colorectal cancer: results from a large population-based cohort study.
Ahmed S; Leis A; Fields A; Chandra-Kanthan S; Haider K; Alvi R; Reeder B; Pahwa P
Cancer; 2014 Mar; 120(5):683-91. PubMed ID: 24222180
[TBL] [Abstract][Full Text] [Related]
8. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA
Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796
[TBL] [Abstract][Full Text] [Related]
9. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members.
Watson P; Lin KM; Rodriguez-Bigas MA; Smyrk T; Lemon S; Shashidharan M; Franklin B; Karr B; Thorson A; Lynch HT
Cancer; 1998 Jul; 83(2):259-66. PubMed ID: 9669808
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study.
Erichsen R; Baron JA; Stoffel EM; Laurberg S; Sandler RS; Sørensen HT
Am J Gastroenterol; 2013 Aug; 108(8):1332-40. PubMed ID: 23774154
[TBL] [Abstract][Full Text] [Related]
11. β-Blocker use and all-cause mortality of melanoma patients: results from a population-based Dutch cohort study.
Livingstone E; Hollestein LM; van Herk-Sukel MP; van de Poll-Franse L; Nijsten T; Schadendorf D; de Vries E
Eur J Cancer; 2013 Dec; 49(18):3863-71. PubMed ID: 23942335
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of preoperative bowel obstruction in stage III colorectal cancer.
Katoh H; Yamashita K; Wang G; Sato T; Nakamura T; Watanabe M
Ann Surg Oncol; 2011 Sep; 18(9):2432-41. PubMed ID: 21369738
[TBL] [Abstract][Full Text] [Related]
13. Isolated tumor cells in regional lymph nodes as relapse predictors in stage I and II colorectal cancer.
Mescoli C; Albertoni L; Pucciarelli S; Giacomelli L; Russo VM; Fassan M; Nitti D; Rugge M
J Clin Oncol; 2012 Mar; 30(9):965-71. PubMed ID: 22355061
[TBL] [Abstract][Full Text] [Related]
14. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.
Han Y; Cai H; Ma L; Ding Y; Tan X; Liu Y; Su T; Yu Y; Chang W; Zhang H; Fu C; Cao G
Eur J Cancer; 2013 Nov; 49(16):3420-30. PubMed ID: 23809767
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
16. A cohort study of metformin exposure and survival in patients with stage I-III colorectal cancer.
Spillane S; Bennett K; Sharp L; Barron TI
Cancer Epidemiol Biomarkers Prev; 2013 Aug; 22(8):1364-73. PubMed ID: 23753040
[TBL] [Abstract][Full Text] [Related]
17. Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients.
Andreoni B; Chiappa A; Bertani E; Bellomi M; Orecchia R; Zampino M; Fazio N; Venturino M; Orsi F; Sonzogni A; Pace U; Monfardini L
World J Surg Oncol; 2007 Jul; 5():73. PubMed ID: 17610720
[TBL] [Abstract][Full Text] [Related]
18. Improved survival in young women with colorectal cancer.
Koo JH; Jalaludin B; Wong SK; Kneebone A; Connor SJ; Leong RW
Am J Gastroenterol; 2008 Jun; 103(6):1488-95. PubMed ID: 18510616
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for survival in colorectal cancer patients.
Laohavinij S; Maneechavakajorn J; Techatanol P
J Med Assoc Thai; 2010 Oct; 93(10):1156-66. PubMed ID: 20973318
[TBL] [Abstract][Full Text] [Related]
20. Does colorectal cancer in ulcerative colitis patients constitute a risk for chemotherapy refractoriness?:a systemic approach by detailed analysis via the electronic tumor base documentation system.
Engelhardt M; Ihorst G; Udi J; Kleber M; Rawluk J; Wäsch R
Onkologie; 2011; 34(12):688-94. PubMed ID: 22156448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
